This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Protagonist Therapeutics (NASDAQ:PTGX), StandardAero (NYSE:SARO)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.B. Riley Securities analyst Mayank Mamtani initiated coverage on Theravance Biopharma, Inc. TBPH with a Buy rating and announced a price target of $28. Theravance Biopharma shares closed at $13.70 on Thursday. See how other analysts view this stock.Leerink Partners analyst Faisal Khurshid initiated coverage o ...